• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.19% Nasdaq Down0.21%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    162.76 Down 2.02(1.23%) 11:37AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 600,333   599,476   555,146   512,495  
    Cost of Revenue69,399  49,439  51,858  39,626  
    Gross Profit 530,934   550,037   503,288   472,869  
    Operating Expenses
    Research Development221,080  129,110  100,661  92,554  
    Selling General and Administrative187,116  183,776  157,665  159,477  
    Non Recurring19,031  33,456  8,303  1,989  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 103,707   203,695   236,659   218,849  
    Income from Continuing Operations
    Total Other Income/Expenses Net3,889  2,195  205  512  
    Earnings Before Interest And Taxes107,596  205,890  236,864  219,361  
    Interest Expense651  549  655  715  
    Income Before Tax106,945  205,341  236,209  218,646  
    Income Tax Expense15,622  52,009  58,478  52,151  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops91,323  153,332  177,731  166,495  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 91,323   153,332   177,731   166,495  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 91,323   153,332   177,731   166,495  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.